CHMP of EMA conveyed negative trend vote of Puma’s MA for neratinib for treating HER2-positive Breast Cancer Read more
Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more
Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH Read more
FDA offers supplementary clearances to Bio-Rad’s IH-System Gel Reagents, Blood Typing Products Read more